Compare Toyota Motor Corp (TM) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Toyota Motor Corp vs Zimmer Biomet Holdings Inc — how do they compare? Toyota Motor Corp trades at $192.78 (market cap $229.22B), while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $18.05B). The key difference: Toyota Motor Corp is far larger — about 12.7× Zimmer Biomet Holdings Inc's market cap, and Toyota Motor Corp pays the higher dividend (3.28%). Which is the better fit depends on your goals.
| TM | ZBH | |
|---|---|---|
Market Cap | $229.22B | $18.05B |
Sector | Consumer Cyclical | Health |
52-Week High | $248.29 | $104.26 |
52-Week Low | $166.50 | $79.58 |
Enterprise Value | $428.61B | $25.11B |
Dividend Yield | 3.28% | 1.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Toyota Motor (TM) trades at $191.45, down 2.87% on the day, amid a bearish technical signal. The stock shows strong fundamentals with a P/E of 8.36 and consistent earnings beats, including Q2 2026 EPS of $7.57 versus $4.68 expected. Revenue grew to $48.04 trillion in 2025, though net income margin softened to 9.91%. Recent news highlights robust RAV4 hybrid demand and strategic manufacturing partnerships.
Outlook remains mixed: valuation appears attractive with low multiples and solid profitability, but technical weakness and rising debt-to-asset ratios pose risks. Analyst sentiment is cautious with 62.5% hold ratings, reflecting concerns over tariff impacts and sales declines in key markets like China.
ZBH trades at $94.22, down 3.93% on the day, with a bearish technical signal but oversold RSI readings. Recent earnings beats and raised 2026 guidance support fundamentals, with revenue growth and strong gross margins. Leadership promotions aim to accelerate commercial transformation, while cash flow trends show operational strength.
The stock offers upside to the $104.88 consensus target, but faces headwinds from debt levels and competitive pressures. Near-term support at $92 is critical; a hold rating aligns with mixed analyst views. Earnings execution and procedure demand growth are key catalysts for valuation expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
